About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
On January 9, PhRMA sponsored the “Endpoints at #JPM23” event, where PhRMA’s president and CEO Stephen J. Ubl joined other health care leaders for a panel titled, “What’s really driving the cost of health care in 2023?”
The group spoke to an in-person and livestream audience, discussing current challenges in the biopharmaceutical supply chain that drive up out-of-pocket costs for patients at the pharmacy counter and debating the best way to approach value assessment.
When
January 9, 2023 at 10:30 AM PT
Speakers:
- Stephen J. Ubl, President and Chief Executive Officer, PhRMA
- Steven (Steve) D. Pearson., President, ICER
- Greg Baker., co-founder and CEO, EmsanaRx
- Drew Armstrong., Executive Editor, Endpoints News (Moderator)
Event
Cost and Value
What’s really driving the cost of health care in 2023?
What’s really driving the cost of health care in 2023? image